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Although the quantity rather than quality of health services has
been the focus historically in developing countries, ample evi-
dence suggests that quality of care (or the lack of it) must be at
the center of every discussion about better health. The follow-
ing examples are illustrative: In one study evaluating pediatric
care in Papua New Guinea, 69 percent of health center workers
reported that they checked for only two of the four examina-
tion criteria for pneumonia cases. Only 24 percent of these
workers were able to indicate correct treatment for malaria.
When clinical encounters were observed at aid posts, providers
met minimal examination criteria in only 1 percent of cases
(Beracochea and others 1995). In a study in Pakistan, only
56 percent of providers met an acceptable diagnostic standard
for viral diarrhea, and only 35 percent met the acceptable stan-
dard for treatment (Thaver and others 1998).
QUALITY DEFINITION AND POPULATION
FRAMEWORK
These deficiencies in quality of care represent neither the
failure of professional compassion nor necessarily a lack of
resources (Institute of Medicine 2001). Rather, they result from
gaps in knowledge, inappropriate applications of available
technology (Murray and Frenk 2000), or the inability of organ-
izations to change (Berwick 1989). Local health care systems
may have failed to align practitioner incentives and objectives,
to measure clinical practice, or to link quality improvement to
better health outcomes.
Increasing evidence, much of it developed since the mid
1990s, shows that quality can be improved rapidly. However, to
improve clinical practice—and thus quality of care—quality
must be defined and measured, and appropriate steps must be
taken (Silimper and others 2002). This chapter highlights
approaches to improving clinical practice and quality of care
that take place over months instead of years. Indeed, better
quality can improve health much more rapidly than can other
drivers of health, such as economic growth, educational
advancement, or new technology.
Definition and Framework
Health systems provide health actions—activities to improve
or maintain health. These actions take place in the context of
and are influenced by political, cultural, social, and institu-
tional factors (shown along the edges of figure 70.1).
Demographic and socioeconomic makeup, including genetics
and personal resources, affect the health status of individuals
seeking care. Access to the health care system is required to
obtain the care that maintains or improves health, but simple
access is not enough; the system’s capacities must be applied
skillfully. Thus, quality means optimizing material inputs
and practitioner skill to produce health. As the Institute of
Medicine defines it, quality is “the degree to which health
services for individuals and populations increase the likeli-
hood of desired health outcomes and are consistent with
current professional knowledge” (Institute of Medicine 2001,
244).
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Elements of Quality. Quality comprises three elements:
• Structure refers to stable, material characteristics (infra-
structure, tools, technology) and the resources of the organ-
izations that provide care and the financing of care (levels of
funding, staffing, payment schemes, incentives).
• Process is the interaction between caregivers and patients
during which structural inputs from the health care system
are transformed into health outcomes.
• Outcomes can be measured in terms of health status,
deaths, or disability-adjusted life years—a measure that
encompasses the morbidity and mortality of patients or
groups of patients. Outcomes also include patient satisfac-
tion or patient responsiveness to the health care system
(WHO 2000).
Structural measures are the easiest to obtain and most com-
monly used in studies of quality in developing countries. Many
evaluations have revealed shortages in medical staff, medica-
tions and other important supplies, and facilities, but material
measures of structure, perhaps surprisingly, are not causally
related to better health outcomes (Donabedian 1980). Although
higher technology or a more pleasant environment may be con-
ducive to better-quality care, the evidence indicates only a weak
link between such structural elements and better health out-
comes (Donabedian 1988). The notable exceptions are cases in
which physical improvements either increase access to primary
care in very poor settings or increase the volume of a clinical
procedure, such as cataract surgery, that is specifically linked to
better health outcomes (Javitt, Venkataswamy, and Sommer
1983). At best, however, structure is a blunt approximation of
process or outcomes; structural improvements by themselves
rarely improve the health of a population.
Process, by contrast, can be measured with every visit to a
provider. Measuring process is difficult, however, particularly
in developing countries. The private nature of the doctor-
patient consultation, a lack of measurement criteria, and the
absence of reliable measurement tools have limited the ability
to assess process (Peabody, Tozija, and others 2004). However,
new methods are being developed that can provide valid meas-
urements of clinical practice (Thaver and others 1998). In addi-
tion, evidence-based clinical studies have steadily revealed
which process measures lead to better health outcomes. This
combination of ubiquity, measurability, and linkage to health
outcomes makes the measurement of process the preferred way
to assess quality.
Although good outcomes are the objective of all health
actions, outcomes alone are not an efficient way to measure
quality for two reasons. The first is the quality conundrum. A
patient may receive poor-quality care but may recover fully, or
a patient may receive high-quality care for an illness such as
cerebral malaria and still not recover. Second, adverse health
outcomes are relatively rare and obviously do not occur with
every encounter.
The classic framework of structure-process-outcome is well
established. However, in recent years the concept of quality has
been expanded to include specific aims for improvement. For
example, the Institute of Medicine’s (2001) landmark report,
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Crossing the Quality Chasm, broadens the concept to include
other, more contextual elements to illuminate how process
changes can improve care. It focuses on six aims: patient safety,
effectiveness, patient centeredness, timeliness, efficiency, and
equity (see box 70.1).
Quality Assessment Perspectives. We can look at the Institute
of Medicine’s aims from two perspectives: patient perception,
and technical or professional assessment. Patients’ perceptions
of quality depend on their individual characteristics and affect
their compliance, follow-up decisions, and long-term lifestyle
changes (Zaslavsky and others 2000). Interpersonal relation-
ships, cultural appropriateness, and gender sensitivity—long
thought to be luxuries of wealthier countries—are also major
determinants of patient access and utilization in developing
countries. These findings have led to the inclusion of patient
satisfaction and patient responsiveness as outcome measures.
Technical assessment concerns whether providers meet nor-
mative standards for appropriateness of care or adherence to
explicit evidence-based criteria. Although patient perception or
satisfaction is important, researchers increasingly rely on objec-
tive, evidence-based quality criteria that can be more readily
linked to better health outcomes at both the individual and the
population levels.
Population-Level Considerations. Quality is typically
assessed through the interaction between individual doctors
and patients. However, emerging evidence shows that the
average quality of care given by groups of doctors and other
providers is an important determinant of overall community
health status. For example, in a cross-sectional analysis in the
former Yugoslav Republic of Macedonia, researchers found not
only that patients’ heath status was significantly higher in areas
where quality was higher but also that the overall self-reported
health status of those members of the general population who
had not recently received care was higher (Peabody, Tozija, and
others 2004).
Our quality-of-care framework supports these findings.
When process is improved among groups of providers,the aggre-
gate improvement in quality leads to better health outcomes for
the entire patient population. In addition, resources can be allo-
cated among clinical interventions based on actual effectiveness
and the overall impact of care on the population. For example,
cancer chemotherapy may be available and may prolong the lives
of cancer patients.However, it may result in fewer lives saved than
the expansion of coverage of directly observed treatment short-
course coverage for tuberculosis patients.
QUALITY OF CARE IN DEVELOPING COUNTRIES
The process of providing care in developing countries is often
poor and varies widely. A large body of evidence from indus-
trial countries consistently shows variations in process, and
these findings have transformed how quality of care is per-
ceived (McGlynn and others 2003). A 2002 study found that
physicians complied with evidence-based guidelines for at least
80 percent of patients in only 8 of 306 U.S. hospital regions
(Wennberg, Fisher, and Skinner 2002). It is important to note
that these variations appear to be independent of access to care
or cost of care: Neither greater supply nor higher spending
resulted in better care or better survival. Studies from develop-
ing countries show similar results. For example, care in tertiary
and teaching hospitals and care provided by specialists may be
better than care for the same cases in primary care facilities and
by generalists (Walker, Ashley, and Hayes 1988).
One explanation for variation and low-quality care in the
developing world is lack of resources. Limited data indicate,
however, that high-quality care can be provided even in environ-
ments with severely constrained resources. A study in Jamaica,
which used a cross-sectional analysis of government-run
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The Institute of Medicine’s Six Elements of Quality
Box 70.1
1. Patient safety. Are the risks of injury minimal for
patients in the health system? 
2. Effectiveness. Is the care provided scientifically sound
and neither underused nor overused?
3. Patient centeredness. Is patient care being provided in a
way that is respectful and responsive to a patient’s pref-
erences, needs, and values? Are patient values guiding
clinical decisions?
4. Timeliness. Are delays and waiting times minimized?
5. Efficiency. Is waste of equipment, supplies, ideas, and
energy minimized?
6. Equity. Is care consistent across gender, ethnic, geo-
graphic, and socioeconomic lines?
Source: Institute of Medicine 2001.
primary care clinics, showed that better process alone was linked
to significantly greater birthweight (Peabody, Gertler, and
Liebowitz 1998). A study in Indonesia attributed 60 percent of
all perinatal deaths to poor process and only 37 percent to eco-
nomic constraints (Supratikto and others 2002).
Cross-system or cross-national comparisons provide the
best examples of the great variation in clinical practice in devel-
oping countries. In one seven-country study, researchers
directly observing clinical practice found that 75 percent of
cases were not adequately diagnosed, treated, or monitored and
that inappropriate treatment with antibiotics, fluids, feeding,
or oxygen occurred in 61 percent of cases (Nolan and others
2001). Another study compared providers’ knowledge and
practice in California and FYR Macedonia, using vignettes to
adjust for case-mix severity. Although the quality of the overall
or aggregate process was lower in FYR Macedonia, a poor
country, the top 5 percent of Macedonian doctors performed as
well as or better than the average Californian doctor (Peabody,
Tozija, and others 2004).
In a study commissioned for this chapter, an international
team measured quality in five developing countries (China,
El Salvador, India, Mexico, and the Philippines), using the
same clinical vignettes at each site. The team evaluated the
process for common diseases according to international,
evidence-based criteria. Quality varied only slightly among
countries. The within-country range of quality of doctors was
10 times as great as the between-country range. Such wide
variation strongly suggests that efforts to improve health 
status must involve policies that change the quality of clinical
care.
POLICY INTERVENTIONS TO IMPROVE QUALITY
The success of quality improvement policies can be measured
by their ability to raise the average level of health and reduce
variation in quality. Two types of policies are intended to
improve quality and thus health outcomes:
• those that influence provider behavior by altering the struc-
tural conditions of organization and finance or that involve
the design and redesign of health care systems
• those that directly target provider behavior at the individual
or the group level.
Within each category, the evidence is examined to see the
effect of the policy on the health outcomes of populations.
Interventions Affecting Provider Practice by Changing 
Structural Conditions
Although structural components such as materials and staff
are not strongly linked to outcomes, other components of
structure—organization and finance—can influence process
by changing the socioeconomic, legal and administrative,
cultural, and information context of the health care system.
Legal Mandates, Accreditation, and Administrative Regula-
tions. Legal mandates, accreditation, and administrative regu-
lations affect quality by controlling entry into the practice of
health care. These policies include the licensing of profession-
als and facilities, their accreditation or certification to perform
certain procedures, and the formal delineation of functions
that various types of health workers can legally perform.
Although these policies assume that providers’ prior qualifica-
tions are good predictors of actual performance in health care
delivery, there is little evidence that such policies have a positive
effect on process or outcomes. They are more successful at bar-
ring unqualified persons from practicing than at ensuring
quality among those who are allowed to practice. A review of
health sector regulations in Tanzania and Zimbabwe, for exam-
ple, revealed that the regulations primarily control entry into
the market and ensure a minimum standard of quality
(Kumaranayake and others 2000).
Hospital accreditation, with its periodic reviews of health
facility performance standards, can potentially provide ongo-
ing regulatory pressure for improvement. To date, research has
not demonstrated that hospital accreditation programs are
linked to improvements in health outcomes. In a randomized
controlled trial of a hospital accreditation program in the
KwaZulu-Natal province of South Africa, researchers showed a
conclusive link between the implementation of the program
and improvements in the accreditation standard indicators.
However, they were unable to link those indicators to improve-
ments in health outcomes (Salmon and others 2003).
Malpractice Litigation to Enforce Legal Mandates To be
effective in promoting quality, malpractice litigation must rely
on adequate legal and judicial systems, which are deficient in
most developing countries. In India, one of the few developing
countries with the appropriate legal structure in place, inclu-
sion of the medical sector under the Consumer Protection Act
of 1986 allows victims to receive redress for negligent medical
practice. Although improvements have resulted, some argue
that the system needs greater involvement of professional
organizations to be effective (Bhat 1996).
Professional Oversight Peer review is as old as professional
societies. The power and the influence of such societies vary
widely among countries (Heaton 2000). Large provider organ-
izations, such as hospitals or public health institutions, often
routinely collect information on provider practices and patient
outcomes and use those data to guide, educate, supervise, dis-
cipline, or recognize providers. In the Philippines, public health
managers used a checklist of 20 observable behaviors against
which health workers in remote provinces were rated. The
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performance of providers in facilities where workers were
reviewed was significantly better than in comparable facilities
that did not adopt the reviews (Loevinsohn, Guerrero, and
Gregorio 1995). Others, however, assert that the “quality by
inspection” environment engendered by oversight leads to an
antagonistic relationship between workers and managers and
precludes cooperative problem solving and continuous
improvement (Berwick 1989). A qualitative study evaluating
supervisor-provider interactions in health care facilities in
Zimbabwe found that supervisors were adept at giving techni-
cal feedback but were not as proficient at making suggestions
for improvement or at working with providers and patients to
solve problems (Tavrow, Kim, and Malianga 2002).
National and Local Clinical Guidelines In many industrial
countries, evidence-based clinical guidelines are used to ensure
high-quality care, better health outcomes, and cost-effective
treatments. (Examples of institutions supporting this approach
are the U.K. National Institute for Clinical Excellence, the U.S.
Agency for Healthcare Research and Quality, and the Dutch
College of General Practitioners.) Guidelines are typically
developed for a clinical disease or symptom. They should be
derived from evidence-based criteria resulting from well-
designed clinical investigations or expert opinion. Because they
are derived from empirical studies, guidelines in developing
countries can, in principle, be identical to those in industrial
countries. When resource constraints limit transferability, diag-
nostic and treatment guidelines may have to be modified.
Technologies such as x-ray studies have gained widest accept-
ance in preventive and primary care services, such as integrated
management of childhood illness, where they serve both as
clinical standards and as educational guides. Including physi-
cians in the development and review of guidelines has proved
particularly effective in the challenging process of implement-
ing guidelines.
Sharing Information on Quality Improvement Technology.
Worldwide interest in quality has given rise to new professional
bodies, scientific publications, and institutions dedicated to
sharing ideas and innovations in quality improvement.
Organizations such as the Robert Wood Johnson Foundation,
the Nuffield Trust, and the Institute for Healthcare
Improvement cultivate ideas for improvement, bring people
and organizations together to learn from each other, and take
action to achieve results. Although the sharing of information
on quality health care practices has long been an established
part of provider education and training networks, the sharing
of information on successful systemwide policies for process
improvements could potentially accelerate the scale-up of
quality practice.
One organization active in developing countries is the
Council on Health Research for Development (COHRED),
which promotes, facilitates, and evaluates the Essential
National Health Research strategy in such countries as Benin,
the Arab Republic of Egypt, and Indonesia. COHRED aims to
develop a system of effective health research to improve health
services, including quality of care. The Quality Assurance proj-
ect funded by the U.S. Agency for International Development
has studied and shared information about quality in the devel-
oping world since 1990. Under the Quality Assurance project
umbrella, researchers have studied and implemented quality
measurement and improvement interventions and have used
these case studies to develop a library of tools and articles to
promote global quality improvement.
Public-Private Provision of Care. In most health care systems,
a professional regulatory framework governs the network of
civil servants delivering health care. These civil servants operate
alongside autonomous, self-governed, private providers—
independent for-profit physicians and health clinics and non-
profit nongovernmental organizations (NGOs). Two conclu-
sions arise from the often heated debate about the right balance
between public and private services. First, private practitioners
provide a significant amount of care in developing countries.
Second, though there is no one prescription for striking the
right public-private mix, in some cases the public regulatory
framework has led to private provision of higher-quality care.
The government of Senegal successfully contracted with
community-based groups for preventive nutrition services.
Eighteen months after nutrition services were implemented,
severe malnutrition disappeared among children age 6 to
11 months (Marek and others 1999). The success of the pro-
gram has led to its expansion nationwide.
Targeted Education and Professional Retraining. Continuing
medical education is a common approach to improving clini-
cal practice, but it neither changes clinical practice nor
advances health outcomes (Davis and others 1995). Newer
techniques—targeted education, case-based learning, and
interactive and multimodel teaching techniques—have had
some success. In Guatemala, distance education targeting diar-
rhea and cholera case management increased accurate assess-
ment and classification of diarrhea cases by 25 percent.
Rehydration did not improve, however, and improvements in
counseling were insignificant (Flores, Robles, and Burkhalter
2002). In Tanzania, training staff in the control of acute respi-
ratory infections of young children yielded reductions in
under-five mortality within two years (Mtango and Neuvians
1986).
Organizational Change. In recent years, organizational
change in the health care system has been shown to influence
quality of care and to further the six aims of the Institute of
Medicine by focusing on the continual design and redesign of
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systems. The emphasis is on developing organizational and
individual capabilities where they most profoundly affect the
process of care. Design and redesign interventions assume that
simply adding a new resource or a new process in isolation will
not improve care because better care is the product of many
processes working together. Although change interventions
have not been widely used in the developing world because
they require large investments to plan and implement, four
related models of organizational change have been successful in
changing provider practice in developing nations:
• Total Quality Management in health care Advances in
business management practices to continually design and
redesign systems for quality improvement have been effec-
tively adapted for health systems. In Total Quality Manage-
ment, also known as Continuous Quality Improvement,
teams use mutually reinforcing techniques in a cycle of plan-
ning, implementing, evaluating, and revising to improve the
quality of clinical and administrative processes. These tech-
niques include process mapping, statistical quality control,
and structured team activities. In rural Bihar, India, private
practitioners who treat sick children were provided with
standard case-management information, were given feed-
back on their performance, and were tracked and monitored
over time. This strategy produced significant improvements
in practitioners’ case-management skills (Chakraborty,
D’Souza, and Northrup 2000). In Malaysia, anesthesia safety
has been improved through the implementation of
consensus-based protocols that emphasize (a) communica-
tion among the operating, recovery, and ward team mem-
bers; (b) individual feedback; and (c) frequent monitoring
to identify areas for improvement (Tan 1999).
• Collaborative Improvement Model The early success of Total
Quality Management techniques has given rise to a related
model, the Collaborative Improvement Model. It addresses
broad and complex systemic processes within health care
systems and has facilitated the scale-up of quality improve-
ments.This model,designed to continuously improve organ-
izational and individual performance, comprises four ele-
ments: definition of an aim, measurement, innovation, and
testing to see whether the innovation meets the original aim.
This approach strikes a pragmatic balance between the need
for action and the need to be scientifically grounded. It has
been used with success in Peru and the Russian Federation. In
Peru, the collaborative improvement model was used by mul-
tidisciplinary teams in 41 clinics to design changes aimed at
achieving world-class tuberculosis care. The preliminary
results have led to impressive changes in the process of care,
but it is too early to determine whether they have been effec-
tive in improving quality (Berwick 2004).
• Plan-Do-Study-Act cycle The Plan-Do-Study-Act (PDSA)
cycle calls for action-oriented learning in quality improve-
ment. Team members using the PDSA model design a
quality-improvement intervention (plan), implement it on
a small scale (do), evaluate the results (study), and imple-
ment or alter the intervention accordingly (act). Often mul-
tiple PDSA cycles are necessary before the appropriate
improvement method can be identified. All improvement
techniques that involve the design and redesign of systems
use some form of the PDSA cycle. Successful scale-up of a
PDSA prototype is possible with careful leadership over-
sight. A team of investigators in Russia’s Tula province
developed a series of successful interventions for adults who
have poorly controlled hypertension. The interventions,
which were started in 20 clinics, were expanded to 500 clin-
ics within 18 months. The scale-up resulted in a sevenfold
increase in patients receiving hypertension management at
the primary care level and an 85 percent reduction in admis-
sions for hypertension. In Tver province, the same group
addressed problems related to prenatal care. They began
with 5 hospitals and scaled up to cover all 42 hospitals and
all maternity clinics in the province. The result was a 99 per-
cent reduction in newborns with hypothermia and a reduc-
tion in pregnancy-induced hypertension from 44 percent
to 6 percent (Berwick 2004). Although the experience of
researchers implementing interventions that are based on
system redesign in the developing world has been largely
positive, it is not clear whether the resources and leadership
exist to bring these interventions to scale through country
or regional policies. Further evidence is needed concerning
the real-world feasibility and cost-effectiveness of system
redesign.
• Internal enabling environment Creating the right environ-
ment for change involves leadership and leadership training,
clinicians empowered to make quality improvement deci-
sions, and resources for quality improvement planning
activities (Silimper and others 2002). The internal enabling
environment in Costa Rica promoted strong leadership that
led to the adoption of structural adjustment loans in the
early stages of health sector reforms. The loans were used to
maintain such public health programs as mother and child
nutrition, even though public spending dropped and prices
increased dramatically (Peabody 1996). An enabling envi-
ronment can also be created by teams of individuals, each
representing different stakeholder groups (physicians,
nurses, staff members, patients, and so forth) or simply by a
strong leader with an interest in teamwork and the resources
to support a discrete quality improvement function for team
members.
Interventions Directly Affecting Provider Practice
Practitioners are often forced to provide care in uncertain set-
tings. Technical limitations may reduce the ability to diagnose
1298 | Disease Control Priorities in Developing Countries | John W. Peabody, Mario M. Taguiwalo, David A. Robalino, and others
or predict outcomes, or they may have only probabilistic
knowledge about the efficacy of their proposed treatment for a
particular patient. The nature of clinical practice is often soli-
tary, and physicians have few available ways to gauge their clin-
ical acumen and skills. Performance-based feedback, however,
can reward high-quality care and increase knowledge about
appropriate actions. If the feedback mechanism is effective, it
can also serve as the basis for establishing systemwide incen-
tives for improving quality of care.
Training with Peer Review Feedback. In Mexico City, physi-
cian retraining on treatment of diarrhea, combined with the
concurrent creation of a peer-review structure, decreased the
use of antibiotics and increased the use of oral rehydration
therapy (ORT). These improvements continued to be seen in
a follow-up evaluation 18 months later (Gutierrez and others
1994). The approach has been effectively expanded to pre-
scribing practices for rhinopharyngitis among primary care
physicians, using an interactive training workshop and a man-
agerial peer-review committee (Perez-Cuevas and others
1996).
Performance-Based Remuneration. A potentially powerful
instrument for accelerating quality improvements involves
making payments directly to providers who meet quality stan-
dards that are based on process indicators associated with
favorable patient outcomes. Systems that tie performance to
remuneration use relatively small incentives—equivalent to
3 to 10 percent of the provider’s total compensation.
Performance-based remuneration has been successfully used
in the United States to compensate both private and public
providers (McBride, Neiman, and Johnson 2000).
Examples of performance-based incentives come from
developing countries too. The Nicaraguan Ministry of Health
has implemented a pilot program in six hospitals that offers an
incentive bonus (a maximum average of 17 percent of hospital
revenue) for facilities that achieve performance targets that
include quality measures (Jack 2003). In Haiti, a performance-
based payment scheme was set up for NGOs that provided
services to the population. The scheme resulted in all three par-
ticipating NGOs reaching target immunization coverage rates
(Eichler, Auxila, and Pollock 2001). Thus, payment for specified
and observable performance (in terms of provider effort, client
coverage, or health impact on the population) can be usefully
applied to NGOs and private providers.
The specific features of performance-based remuneration
are crucial. A study evaluating the South African government’s
experience in contracting with private organizations to operate
district hospitals found no cost savings—in fact, the govern-
ment was spending more than if it provided the services itself.
The contracting may have failed because remuneration was not
based on specific process or outcome measures. Instead, the
contractor’s obligation, the methods of monitoring perform-
ance, and the sanctions for nonperformance were only mini-
mally specified (Broomberg, Masobe, and Mills 1997).
High Volume of Care. Evidence exists that a high volume of
care by individuals or institutions leads to better health out-
comes (Habib and others 2004).Physician experience (learning)
and practice (repetition) lead to fewer complications, less
resource use, and better quality for a variety of procedures, such
as cataract surgery and laparoscopy (Brian and Taylor 2001).
More complex procedures, including endarterectomy, cancer
surgery,and coronary bypass surgery,have shown similar effects.
Volume effects leading to better health outcomes are not
confined to surgical procedures (Zgibor and Orchard 2004).
Facilities specializing in the care of chronic diseases such as dia-
betes, myocardial infarction, and heart failure are also associ-
ated with better outcomes. Debate exists over how much of the
volume effect is due to specialist care. The benefits of high-
volume care persist, however, even after controlling for referral
and case-mix biases. When carefully trained nonphysicians are
substituted for physicians, volume effects persist but can be
accomplished at significantly lower costs. In one study, nurse
practitioners and physician’s assistants were able to provide
high-quality care for common outpatient conditions such as
hypertension, diabetes, asthma, otitis media, pharyngitis, and
back pain at substantially lower costs than that of physicians
(Douglas and others 2004).
Performance-Based Professional Recognition. Providers
work in a community of peers in which professional status,
prestige, and recognition are often as valuable as material
rewards. Nonmonetary incentives, such as public recognition
or disclosure, administrative privileges, and awards from pro-
fessional organizations, can promote improvements in quality.
Uganda, for example, implemented the Yellow Star Program as
part of a broader health services improvement project. This
program evaluated health facilities on a quarterly basis, using
35 indicators of technical and interpersonal quality, and
awarded a large yellow star to facilities that scored 100 percent
in two consecutive quarters. The star was then prominently dis-
played outside the facility.
The Mexican Ministry of Health has implemented a strategy
that combines the accreditation and the training strategies
discussed earlier with nonmonetary incentives. The National
Crusade for Quality in Health Care introduces quality-oriented
incentives to health facilities and medical schools. It also
includes public recognition in an effort to encourage learning
and to change practice. The National Crusade has already gen-
erated measurable improvements in the responsiveness of
state-level health systems (Secretaría de Salud de Mexico 2003).
Both types of policies examined in this section are associ-
ated with better quality and better health outcomes—lower 
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premature mortality and avoidable morbidity, increased
patient satisfaction, and more health-seeking behaviors. When
effective, these policies result in increased coverage rates, better
prescribing patterns, and increased adherence to clinical guide-
lines. They can spell the difference between an individual’s
survival or death, between an individual benefiting from the
encounter with the health sector or being harmed by it, and
between an individual and society rising from poverty or sink-
ing deeper into it.
MEASURING QUALITY
Improving quality requires that we measure it accurately. The
successful outcomes discussed in the previous section rely on the
links between policy and changes in clinical practice. Such links,
however, can be created and demonstrated only when valid and
reliable measures of process are easily understood, inexpensive
to obtain, resistant to manipulation, and related to better health
outcomes.
Measuring Structure
Material measures of structure abound. Numerous facility-
based surveys in developing countries have cataloged capital
equipment and staffing levels, and financial reports track budg-
ets and expenditures (but rarely production costs). Facility
inventories of drugs and supplies are generally available; service
utilization figures are routinely reported to national-level
authorities. Such measurements, however, are often beside the
point. Even when material structural deficiencies are corrected,
they are not reliably linked to changes in health outcomes.
Measuring the organization and financing of health care is more
difficult. Although descriptions of the organization and financ-
ing of health systems exist, objective functional assessments of
systems (such as patient flows, the patient referral system, or
details of the relative pricing of services) are less often available.
Measuring Process
Technical advances have mitigated longstanding difficulties in
measuring process. Five approaches and their strengths and
weaknesses merit consideration: chart abstraction, direct
observation and recording of visits, administrative data, stan-
dardized patients, and clinical vignettes.
Chart Abstraction. Chart abstraction, or review of the med-
ical record, has long been used to measure technical quality.
Such familiar quality evaluations as clinical audits, physician
report cards, and profiles are based on chart abstraction. The
core strength of the medical record is that it is ubiquitous and
can generally be obtained after each encounter. Chart reviews,
however, suffer from problems of legibility when notes are
handwritten. Often they are generated for reasons other than
recording the actual events of the clinical visit (legal protection
or obtaining payments, for example) and thus lack crucial
clinical details. One prospective study showed that charts iden-
tified only 70 percent of items performed during the clinical
encounter (Luck and others 2000). In a related analysis, 6.4 per-
cent of the items recorded in the chart were false and had never
really occurred.
Where resources and infrastructure are sufficient, the elec-
tronic medical record (EMR) is becoming a priority for health
systems worldwide. EMR technology promotes uniformity, leg-
ibility, and communication, which can lead to guideline use
and reduce prescription errors. It also holds the promise of
managing populations rather than individuals by aggregating
patients into groups. However, the EMR has not always lived up
to its potential. In many countries, some impressive successes
have occurred—as have spectacular failures, costing billions of
dollars (McConnell 2004). The great heterogeneity in record-
keeping practices, problems with medical records (both paper
and electronic), and costs of trained medical abstractors have
led to a search for other reliable ways to measure quality.
Direct Observation and Recording of Visits. Direct observa-
tion and recording of visits is a commonly used approach in
developing countries (Nolan and others 2001). Ethically, the
provider and the patient must be informed of the observation
or recording, which introduces participation bias because
provider behavior may change as a result of being evaluated. In
addition, trained observers are costly, and variation between
observers is difficult to remedy.
Administrative Data. Administrative data, collected for pur-
poses of managing the delivery of care, are available in all but
the poorest settings. A data collection system, once established,
is ubiquitous and can provide information on charges and
many cost inputs. Administrative data, however, lack sufficient
clinical detail to be useful in evaluating process. In a 2003 study,
an incorrect diagnosis was recorded in the data 30 percent of
the time (although the diagnosis was made correctly). Overall,
these data reflected the actual clinical diagnosis only 57 percent
of the time (Peabody, Luck, Jain, and others 2004). As informa-
tion systems advance, accuracy problems may be mitigated,
although the lack of adequate clinical detail will continue to
limit the use of administrative data.
Standardized Patients. Standardized patients can be a gold
standard for process measurement (Luck and Peabody 2002).
Trained to simulate illness, standardized patients present them-
selves unannounced into a clinical setting to providers who
have previously given their consent to participate in the study.
At the conclusion of the visit, the standardized patient reports
on the technical and interpersonal elements of process.
Standardized patients are reliable over a range of conditions
and provide valid measurements that accurately capture
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variation in clinical practice among providers over time.
However, they are expensive and useful only for adult condi-
tions and only those conditions that can be simulated. Thus,
they are not practical for routinely evaluating quality.
Clinical Vignettes. Clinical vignettes were developed explicitly
for measuring quality within a group of providers and
evaluating quality at the population level. Vignettes are respon-
sive to variation in quality, and providers readily accept them if
they are given anonymously (Peabody, Luck, Glassman, and
others 2004). More than 20 vignettes have been used in 13
countries around the world. They can be administered on
paper, by computer, or over the Internet. Providers are typically
presented with several cases. When process is being measured
for many providers, each provider is presented with the same
case or set of cases, thus eliminating the need for case-mix
adjustment. The provider completing the vignette is asked to
take a history, do an examination, order the necessary tests,
make a diagnosis, and specify a treatment plan. The questions
are open ended and include interactive responses that simulate
the visit and evaluate the physician’s knowledge. In two sepa-
rate, prospective validation studies among randomly selected
providers, vignettes consistently demonstrated greater predic-
tive validity of process than did the abstracted medical record.
Vignettes have been validated against the gold standard of
standardized patient visits, and they reflect actual clinical prac-
tice, not just physicians’ knowledge. Vignettes have several
other advantages. Because exactly the same case can be given to
many providers, vignettes are useful for comparison studies.
They are also useful for pre- and postevaluations of policy
interventions designed to improve quality. Finally, they are
inexpensive to administer and straightforward to score, making
them particularly useful in developing countries.
ECONOMIC BENEFITS AND COSTS 
OF QUALITY CARE
Policy interventions can lead to higher-quality process of care
and can rapidly improve a population’s health outcomes, but is
quality improvement cost-effective? This section shows that it
is. We compare the economic benefits of better quality of care
at the individual and population levels with the costs of imple-
menting quality improvement interventions. We then discuss
why these interventions not only increase individual and social
welfare but also are cost-effective in the long run.
Individual Economic Benefits
Individuals benefit from better quality of care because they are
physically, emotionally, and mentally healthier. These benefits
can be quantified subjectively by self-report, objectively by
physiological assessments (such as blood pressure), and mone-
tarily by measuring income. Other things being equal, a healthy
individual generates more income than one who is often sick.
This benefit goes beyond the period of illness. Research on early
childhood development has shown that higher-quality prenatal
and postnatal care not only decreases mortality but also
improves subsequent school performance, which is critical to
future labor productivity (Van der Gaag 2000). The monetary
benefits of better individual health can be assessed by examining
the individuals’ expected income in the context of a life cycle
model. Expected income depends on the risk of death at various
points in time and the corresponding opportunities for educa-
tional attainment. This scenario can be simulated by improving
quality and then estimating how much the higher quality lowers
mortality and increases education attainment, both of which
increase an individual’s future income (see figure 70.2).
Social Macroeconomic Benefits
Societies that have healthier populations also have higher levels
of human capital and a greater capacity to generate wealth.
Higher quality of care for the individual increases society’s
human capital by reducing both the number of premature
deaths (thus increasing the labor force) and the amount of tem-
porary or permanent disability (thus improving worker pro-
ductivity). Providers and insurers also benefit from lower costs
by avoiding unnecessary or inappropriate care. Thus, society
benefits from both better health and lower public expenditures
for treatment, which can then be reallocated to other productive
uses. Interventions that improve quality have an especially high
social value when they have large positive externalities (for
instance, when better process reduces the incidence of a com-
municable disease). Sometimes, however, society benefits but
some stakeholders do not. For example, physicians who provide
better preventive care may experience less demand for their cur-
ative services and associated resources.
Several attempts have been made to estimate the correlation
between health outcomes and long-term economic growth.
The high prevalence of such diseases as malaria has been linked
in some studies to a slowing of economic growth by one to two
percentage points per year. These studies were severely limited
by the number of countries and by the many unobserved fac-
tors excluded from the models (Sachs 2001). These limitations
suggest another way to estimate the benefits of higher quality
on health outcomes and long-term economic growth. Because
diagnostic accuracy and treatment of malaria can be improved
with better-quality care, improving quality should increase
national income through reductions in mortality rates.
Indeed, cross-country data suggest that a one-year increase
in life expectancy is associated with an increase in the gross
domestic product (GDP) growth rate of 1 to 4 percentage points
(Bloom, Canning, and Sevilla 2001). Our own simulations show
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Source: Authors’ calculations. 
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that quality improvements can result in as much as a 5 percent
annual reduction in child mortality rates, which can generate,
over 50 years, economic gains equivalent to 18 percent of cur-
rent GDP (see figure 70.3). Similar results would be obtained if
the effect of better quality on morbidity and disability were
simulated.
Economic Costs
Policies that improve the quality of care have both direct and
indirect costs. Direct costs relate to the human and physical
resources needed to implement the intervention. Indirect costs
come from more subtle changes, including alterations in the
quantity of health services provided, in provider demand for
various inputs (such as equipment and medication), in the
market prices of heath care, in government health budgets, and
ultimately in the macroeconomy. For interventions at the local
level, such as training doctors in a particular region, it is usually
sufficient to measure direct costs. Although the level of
detail required can be overwhelming when the interventions
are complex, the calculations are usually straightforward. The
costs of local interventions depend on local prices of such
inputs as labor, transportation, training kits, food, space rental,
and accommodations. The cost of training providers in the
appropriate treatment of childhood illnesses ranges from a
low of US$1 to a high of US$430 (Santoso, Suryawati, and
Prawaitasari 1996).
The direct and indirect costs of interventions at the central
or local government level are harder to quantify. Expanding
training programs to all public providers, enforcing standards
for private and public providers, changing payment sys-
tems, and developing policies to protect consumers against
malpractice are macro-level interventions that have direct
program-level costs. They affect the economy as a whole by
changing the allocation of public resources and the relative
prices of goods and services. Macroevaluations of health
policy interventions are seldom conducted, even though sys-
temwide interventions are likely to have the highest effect on
quality and health-related benefits.
Cost-Effectiveness of Improved Process
Two interventions that vividly illustrate the cost-effectiveness
of improvements in clinical practice and outcomes have been
chosen: detection and treatment of acute respiratory illnesses
and appropriate drug use and treatment for diarrhea.
Better Treatment of Pneumonia in Children. Part of the high
mortality from childhood pneumonia in the developing world
can be explained by poor-quality care, which is defined as the
inability either to accurately diagnose or to treat the disease.
Our prototype intervention has two cost components: the cost
of implementing an educational activity for providers and the
cost of treating nonsevere and severe childhood pneumonia.
The former component is based on a study and uses conserva-
tive high-end cost estimations (Kelley and others 2001); the
latter is the midpoint from another study (Stansfield and
Shepard 1990). The number of lives saved depends on the
effect of the intervention—that is, the change in the percent-
age of cases diagnosed and treated; the prevalence rate of both
types of pneumonia; the population covered by each provider;
the case-fatality ratio; and the effectiveness of the treatment.
Both the case-fatality ratio and the effectiveness ratio were
fixed at middle values suggested by earlier work (Stansfield
and Shepard 1990). For the other parameters, a large range of
variation was considered, producing 450 scenarios. Finally, six
impact levels were considered, which were based on two previ-
ous studies (Chakraborty, D’Souza, and Northrup 2000;
Mtango and Neuvians 1986).
The analysis showed that, under average conditions,
improving quality of care for conditions of acute respiratory
illness can be very cost-effective. When the baseline quality is
low and the disease prevalence is high, an intervention that
raises quality has a cost-effectiveness ratio of US$132 to
US$800 per life saved; if the policy intervention is ineffective or
the prevalence of pneumonia is low, the average cost of saving
a life could be more than US$2,000. When 60 percent of cases
are already appropriately diagnosed and treated, the cost-
effectiveness ratio rises to US$5,000 per life saved.1
Better Treatment of Diarrhea. Diarrhea remains one of the
leading causes of childhood morbidity and mortality in the
developing world. The diarrhea incidence rate among children
in resource-constrained countries can reach six to seven
episodes per year (Thapar and Sanderson 2004). ORT is the
accepted standard of care for acute diarrhea. Unfortunately, a
large proportion of cases are still treated with nonrehydration
medication, including antibiotics and antidiarrheals. Improved
diagnosis of dehydration and reduced use of unnecessary med-
ications, however, lead to better outcomes.
Various interventions can make sizable changes in the diag-
nostic and prescribing patterns of providers. Verbal case review,
combined with a package of additional intervention referred
to as INFECTOM (Information, Feedback, Contracting with
Providers to Adhere to Practice Guidelines, and Ongoing
Monitoring), increased the proportion of cases treated correctly
from 16 percent to 48 percent (Bloom, Canning, and Sevilla
2001). One study reports that small group, face-to-face inter-
ventions reduced antimicrobial prescriptions by 16 percent
and antidiarrheal prescriptions by 7 percent among a group
of providers treating acute diarrhea in Indonesia (Santoso,
Suryawati, and Prawaitasari 1996). The same study showed that
formal seminars reduced antimicrobial use by 10 percent and
antidiarrheal use by 7 percent. On the basis of these studies, an
average cost per intervention was used, ranging from US$25 to
US$125.
The savings from switching to a less costly treatment (instead
of antibiotics, for example) were subtracted from the direct
costs that are related to implementing the training activity.
Because other savings, such as those related to a lower use of
inpatient services, were ignored, the estimates are conservative.
Savings could be greater: Two years after an ORT unit was estab-
lished at the Kamuza Central Hospital in Malawi, 50 percent
fewer children with diarrhea were admitted to the pediatric
ward, and those admitted required 56 percent less intravenous
fluid for rehydration (Martines, Phillips, and Feachem 1990).
Again, the number of lives saved depends on the disease
prevalence; the effect of the policy on treatment quality; the
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population covered by each provider; the average case-fatality
ratio, which was set at 6 per 1,000 on the basis of Snyder and
Merson (1982); and the effectiveness of the treatment. For the
latter parameter, reductions in mortality rates following ORT
treatment of 40 to 60 percent and reductions in effectiveness
ratios of 5 to 100 percent have been reported (Shepard, Brenzel,
and Nemeth 1986). Accordingly, the effectiveness ratio was set
at 80 percent. As before, alternative values for the other param-
eters were adopted, generating 450 scenarios.
Educational interventions to improve the quality of care for
treatment of diarrheal diseases are also highly cost-effective. In
general, the cost of saving a life through educational interven-
tions is less than US$500 and could be as low as US$14.
Scenarios with high cost per life saved (more than US$6,000)
are when prevalence rates are low or when implementation
costs for quality-related interventions are high.
Although the data available to estimate the costs and
benefits of health outcomes and process are limited, these
simulations, combined with published reports of successful
policy interventions, clearly show the cost-effectiveness of
interventions that improve health outcomes through better
quality of care. However, reliable measures of quality are neces-
sary to design and evaluate these interventions.
RESEARCH AGENDA ON QUALITY
Most of the issues discussed throughout this chapter represent
important topics for research. Establishing a research agenda
requires prioritizing both the type of research and the topics to
be studied. Quality-of-care research must also strike a balance
between relevance to decision making and excellence in scien-
tific rigor (Frenk 1992).
Observational studies are needed to document the extent
and correlates of quality at various levels: individual providers,
institutional providers, health care systems, and whole popula-
tions. Apart from offering much-needed basic descriptions
(especially in developing countries), these studies can test spe-
cific indicators of the dimensions of quality and can compare
the measurement approaches discussed earlier.
Intervention studies introduce planned changes into health
care settings and assess their consequences. It is fundamentally
important that intervention studies compare one provider
group or policy alternative with another. In addition, control
groups must be used so that any observed change can be
attributed to the intervention itself rather than to another
source of variation. The external validity of studies is often
undermined by the choice of highly specific sites, making it dif-
ficult to generalize the findings and to build a body of sound
evidence. If randomized trials cannot be conducted, the pre-
ferred option is quasi-experimental studies with clear control
groups and longitudinal designs (Peabody and others 1999).
Such studies should be complemented by cost-benefit and
cost-effectiveness analyses. Sometimes, in public health emer-
gencies, for example, control groups may not be practical or
ethical, in which case real-time operations research is an
acceptable substitute.
In the area of research topics, top priority should be given
to quality monitoring and assurance strategies to gain an
understanding of exactly what the health system is contribut-
ing to society and at what cost. Quantifying the associated
costs of different variants of quality monitoring and assurance
strategies should also be a high-priority item on the quality
research agenda. The second priority should be to increase the
evidence base regarding the effects on provider behavior of
public policies concerning quality of care and whether they
lead to better health outcomes. We need to learn more about
the long-term effects of different contracting and remunera-
tion policies on providers’ practices and the consequent
results of such policies for health outcomes. Finally, we need
to understand how contracting and remuneration policies
affect problems unique to the developing world, such as the
use of doctor substitutes and the migration of skilled
providers to wealthier countries.
CONCLUSION
Good quality means that providers are able to manage an indi-
vidual’s or a population’s health care by timely, skillful applica-
tion of medical technology in a culturally sensitive manner
within the available resource constraints. Eliminating poor
quality involves not only giving better care but also eliminating
underprovision of essential clinical services (systemwide
microscopy for diagnosing tuberculosis, for example); stopping
overuse of some care (prenatal ultrasonography or unnecessary
injections, for example); and ending misuse of unneeded serv-
ices (such as unnecessary hysterectomies or antibiotics for viral
infections). A sadly unique feature of quality is that poor qual-
ity can obviate all the implied benefits of good access and effec-
tive treatment. At its best, poor quality is wasteful—a tragedy in
severely resource-constrained health care systems. At its worst,
it causes actual harm.
Despite the urgency of improving health in developing
countries, quality of care has been largely ignored. Both
providers and patients agree this must change, but how can this
goal be reached? From the information marshaled for this
chapter, we can draw five conclusions:
• Better quality leads to better health outcomes in developing
countries.
• Process, the proximate determinant of health outcomes, can
be measured in valid and reliable ways, such as clinical
vignettes and electronic medical records.
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• Measured in the above ways, the process of care in develop-
ing countries is poor.
• The process of care can be improved in the short term.
• Policies affecting structural conditions, including the actual
process of care or the continual design and redesign of the
health care system, have been shown to be effective in devel-
oping countries.
We believe that two broad strategies would help to rapidly
improve health care quality in developing countries:
• encouraging explicit comparative research on outcomes and
process
• disseminating empirical findings on quality variation.
Encouraging Explicit Comparative Research on Outcomes
and Process
Comparisons highlighting different outcomes can be com-
pelling. For example, when 30-day mortality rates for coronary
artery bypass surgery at various facilities were disclosed in the
United States, care started to shift from many low-volume hos-
pitals to high-volume hospitals (Chassin 2002). In developing
countries, comparisons show that the insured are more likely
to have cesarean sections than are the uninsured (Barros and
others 1991). Although critics of comparative analysis are jus-
tified in saying that systems and populations vary, such criti-
cism misses an important point: Differences in outcome high-
light possibilities that help in the search for the underlying
causes of poor quality. Although poor quality may have many
causes, one of them is almost always poor clinical practice,
which can be remedied. We also favor a league or summary
table approach to making comparisons. In this approach, the
providers being compared agree on criteria before prospective
assessments are done. The data for the comparison should be
of the highest quality; the league tables themselves should
be easy to interpret; and the findings should be rapidly avail-
able (Devers, Pham, and Liu 2004). The league table itself
should be set up at the regional, national, and international
levels so that a variety of benchmarks are available.
Implementing quality comparisons will greatly facilitate the
process of policy evaluation and cost-benefit analysis and help
indicate directions for future research. Access to accurate, con-
sistent quality-of-care data will compel external funders, such
as the World Bank, to build quality assurance into their lending
and development programs. As major health programs such as
the Global Fund to Fight AIDS, Tuberculosis, and Malaria are
scaled up around the world, mechanisms to measure and
improve care quality will grow more important.
Disseminating Empirical Findings on Quality Variation
Public dissemination of information on quality, particularly in
low-literacy countries, does not seem to create the individual-
based choice market that many have envisaged. Instead, it
motivates managers and providers to undertake changes that
improve the delivery of care (Schneider and Lieberman 2001).
Outside pressure—perceived or real—appears to extend the
quality debate beyond traditional boundaries, allowing for
innovative collaborations and “out of the box” thinking
(Devers, Pham, and Liu 2004). Nongovernmental and private
organizations involved in health care delivery should also be
required to report basic quality measures, perhaps as a condi-
tion for funding, thus ensuring that similar pressure to improve
quality is exerted outside the public sector.
Public dissemination can create shock waves when poor
quality is “discovered,” leading to popular demand to increase
quality. For example, findings of widespread medical errors in
the United States, estimated to have resulted in as many as
98,000 deaths per year, launched the medical safety revolution
(Institue of Medicine 2001). Dissemination among physicians
and surgeons by means of report cards and ratings has been
effective at changing clinical practice. One advantage of dis-
semination among providers is that the results can be more
refined and technical than ratings meant for wider audiences.
Dissemination is the responsibility of public research and pub-
lic initiative. Because dissemination is inherently controversial,
it requires public financing—even more than other public
goods (Jamison, Frenk, and Knaul 1998).
Ultimately, improving quality is about value. In health care,
price is not a reliable proxy for quality and cannot be used as
a guide. Because patients and consumers cannot directly
observe quality, their ability to demand high-quality services is
limited, and they are often left to settle for a market that has
suboptimal equilibrium and poor quality of care. In addition,
providers often lack knowledge of optimal treatments and
technologies and thus are not aware of how they can produce
higher-quality care. Because the provider-patient interaction
is so private and personal, quality of care is hard to observe
and to measure. New measurement tools, however—such as
clinical vignettes and the electronic medical record—are being
developed and improved. As research links care with out-
comes and cost inputs, we can expect to have more accurate
and reliable data about clinical practice for use in making
quality assessments.
Investments in quality, however, must be judged critically as
well. When we invest in quality, an investment can be beneficial
but can come at a cost. So while quality goes up, value can go
up or down—or costs can go up while quality actually goes
down or stays the same, thus pushing the value of care down
and undermining other efforts to improve quality. Finally, as
we showed for acute respiratory illness and diarrhea, quality
can go up and costs go down, thus increasing overall value.
Examples of this optimal outcome must be actively sought out
and reported, because the success of a given investment cannot
be known in advance (Berwick 2004).
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Improving health status does not have to rely solely on
macroeconomic growth or other long-term development indi-
cators. Health outcomes can be rapidly improved in the short
term by ensuring the appropriateness of the circumstances
or setting under which the health care encounter occurs
(structural improvement) or by increasing the likelihood that
health care providers behave in ways most beneficial to
patients under the prevailing circumstances (process improve-
ment). However, this improvement will not occur sponta-
neously or routinely, despite the best intentions of beneficiar-
ies, providers, and governments. Quality improvement tools
and technologies and information on successful quality
improvement policies must be consistently shared among
developing countries to build local capacity. Funding and
incentives must also be consistent with high quality. Finally,
the political will to ensure that quality becomes a top priority
on the health reform agenda must be sustained.
NOTE
1. As a reference, if the average expected value of a life is close to
US$30,000, even the highest cost-effectiveness ratio found in the analysis
(US$12,000 per life saved), would imply a cost-benefit ratio below 50 per-
cent, assuming an initial average wage of US$1,000 growing at 2 percent
per year, a 5 percent discount rate, and unchanged mortality rates.
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